|
Maryland
|
13-2578432
|
|
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
Large accelerated filer ☒
|
Accelerated filer ☐
|
|
Non-accelerated filer ☐
|
Smaller reporting company ☐
|
|
Emerging growth company ☐
|
| Item 3. |
Incorporation of Documents by Reference
|
| (a) |
the Company’s Annual Report on Form 10-K for the year ended December 31, 2022;
|
| (b) |
the Annual Report on Form 11-K of the Balchem Corporation 401(k) Plan for the year ended December 31, 2022;
|
| (c) |
the Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023;
|
| (d) |
the Company’s Current Reports on Form 8-K filed with the SEC on June 26, 2023; and
|
| (e) |
the description of the Company’s common stock, par value $0.06-2/3 per share, contained in Exhibit 4.1
to the Company’s Annual Report on Form 10-K for the year ended December 31, 2022, together with any amendment or report filed for the purpose of updating such description.
|
|
Item 4.
|
Description of Securities
|
|
Item 5.
|
Interests of Named Experts and Counsel
|
|
Item 6.
|
Indemnification of Directors and Officers
|
|
Item 7.
|
Exemption from Registration Claimed
|
|
Item 8.
|
Exhibits
|
|
Exhibit No.
|
Description
|
|
|
4.1
|
Balchem Corporation Composite Articles of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s
Annual Report on Form 10-K filed on March 16, 2006)
|
|
|
4.2
|
Balchem Corporation Articles of Amendment (incorporated by reference to Exhibit A to the Company’s
Definitive Proxy Statement on Schedule 14A filed on April 25, 2008)
|
|
|
4.3
|
Balchem Corporation Articles of Amendment (incorporated by reference to Exhibit A to the Company’s Definitive
Proxy Statement on Schedule 14A filed on April 28, 2011)
|
|
|
4.4
|
By-laws of the Company, as amended and restated as of December 5, 2022 (incorporated by reference to Exhibit
3.1 to the Company’s Current Report on Form 8-K filed on December 7, 2022)
|
|
|
5.1*
|
Opinion of Greenberg Traurig, LLP
|
|
|
23.1*
|
Consent of RSM US LLP (independent registered public accounting firm to Balchem Corporation)
|
|
|
23.2*
|
Consent of RSM US LLP (independent registered public accounting firm to the Balchem Corporation 401(k) Plan)
|
|
|
Consent of Greenberg Traurig, LLP (included in Exhibit 5.1)
|
||
|
Powers of Attorney (included on the signature page hereof)
|
||
|
99.1
|
2017 Omnibus Incentive Plan, as amended and restated as of June 22, 2023 (incorporated by reference to Appendix A to the Company’s Definitive Proxy Statement on Schedule 14A filed on April 28, 2023)
|
|
|
99.2
|
Balchem Corporation 401(k) Basic Plan Document #01, as amended by the Balchem Corporation 401(K) Plan Amendment of January 1, 2023 (incorporated by reference to Exhibit 10.1 to the Company’s Annual Report on Form 10-K filed on February 24, 2023)
|
|
|
107*
|
Filing Fee Table
|
|
*
|
Filed herewith.
|
|
Item 9.
|
Undertakings
|
| (a) |
The undersigned registrant hereby undertakes:
|
| (1) |
to file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
|
| (i) |
to include any prospectus required by section 10(a)(3) of the Securities Act of 1933, as amended (the “Securities Act”);
|
| (ii) |
to reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate,
represent a fundamental change in the information set forth in the Registration Statement; and
|
| (iii) |
to include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement;
|
| (2) |
that, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein,
and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
|
| (3) |
to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
|
| (b) |
The undersigned registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the registrant’s annual report pursuant to Section 13(a) or Section 15(d)
of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new
registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
|
| (c) |
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions, or
otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
|
|
Balchem Corporation
|
|||
|
By:
|
/s/ Theodore L. Harris
|
||
|
Name:
|
Theodore L. Harris
|
|
|
Title:
|
Chairman, President and Chief Executive Officer
|
|
Name
|
Capacity
|
Date
|
|||
|
/s/ Theodore L. Harris
|
Chairman, President, and Chief Executive Officer
|
June 28, 2023
|
|||
| Theodore L. Harris | |||||
|
/s/ C. Martin Bengtsson
|
Executive Vice President and Chief Financial Officer
|
June 28, 2023
|
|||
| C. Martin Bengtsson | |||||
|
/s/ William A. Backus
|
Vice President and Chief Accounting Officer
|
June 28, 2023
|
|||
| William A. Backus | |||||
|
/s/ David Fischer
|
Director
|
June 28, 2023
|
|||
| David Fischer | |||||
|
/s/ Kathleen Fish
|
Director
|
June 28, 2023
|
|||
| Kathleen Fish | |||||
|
/s/ Daniel Knutson
|
Director
|
June 28, 2023
|
|||
| Daniel Knutson | |||||
|
/s/ Joyce Lee
|
Director
|
June 28, 2023
|
|||
| Joyce Lee | |||||
|
/s/ Matthew D. Wineinger
|
Director
|
June 28, 2023
|
|||
| Matthew D. Wineinger | |||||
|
Date: June 28, 2023
|
Balchem Corporation 401(k) Plan
|
||
|
By:
|
Balchem Corporation, Plan Administrator
|
||
|
By:
|
/s/ Theodore L. Harris | ||
|
Name:
|
Theodore L. Harris | ||
|
Title:
|
Chairman, President and Chief Executive Officer |